News

Nova Mentis to Present Promising Psilocybin Microdose Data at 18th NFXF International Fragile X Conference

Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)…

2 years ago

Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results

Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the…

2 years ago

Hologic Announces Two New Respiratory Assays for the Detection of COVID-19, Flu A, Flu B and RSV

--New assays for the Panther Fusion and Novodiag Systems further build on Hologic’s leading molecular scalable solutions offering to European…

2 years ago

PureTech Founded Entity Akili Announces Public Company Board of Director Nominees

New and recent director nominees include industry trailblazers BJ Jones of Biohaven Pharmaceuticals; Christine Lemke of Evidation Health; Ken Ehlert,…

2 years ago

Akili Announces Public Company Board of Director Nominees

New and recent director nominees include industry trailblazers BJ Jones, Christine Lemke, Ken Ehlert and Chamath Palihapitiya BOSTON--(BUSINESS WIRE)--Akili Interactive…

2 years ago

Ajay Dhankhar Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

NEW YORK--(BUSINESS WIRE)--Lazard Ltd (NYSE: LAZ) announced today that Ajay Dhankhar has joined the firm as a Managing Director in…

2 years ago

Axonics® to Report Second Quarter 2022 Financial Results on August 1

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…

2 years ago

IRLAB Expands Phase IIb/III PD-LIDs Study with Mesdopetam to Support Phase III Program and Expects Completion of Enrollment During the Summer

GOTHENBURG, SWEDEN / ACCESSWIRE / July 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) today announced that the…

2 years ago

Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress

FLT180a generated protective FIX levels with no bleeding or need for FIX replacement The treatment was well tolerated with a…

2 years ago

OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Outset Medical, Inc. and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit…

2 years ago